Fundz

Asgard Therapeutics raised €30M in a Series A financing led by RV Invest and Johnson & Johnson Innovation – JJDC, Inc. to support the development of its lead program AT-108 for cancer immunotherapy.

PRIVATEMar 14, 2024

Amount Raised

€30 Million

Round Type

Series A

LundBiotechnologyFinancial ServicesHealth Care

Investors

IndustrifondenBoehringer Ingelheim Venture FundNovo HoldingsJohnson & Johnson Innovation – JJDCRV Invest

Description

Asgard Therapeutics, a preclinical stage biotech company based in Lund, Sweden, raised €30M in Series A funding. The round was led by RV Invest and Johnson & Johnson Innovation – JJDC, Inc., with participation from existing investors Novo Holdings, Boehringer Ingelheim Venture Fund, and Industrifonden. The company aims to use the funds to support the development of its lead program AT-108 to IND-readiness by 2026, expand and reinforce its research and development team, and accelerate new reprogramming modalities and delivery platforms to strengthen the pipeline.

Who else raised in Financial Services and Biotechnology around the same time

Companies in the same sectors as Asgard Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • FOXO Technologies raised $110K on April 28, 2024.
  • Ajax Therapeutics, Inc. raised $95M on April 26, 2024.
  • Variantyx raised $36M (Funding Round) on April 26, 2024.
  • Owlstone Medical raised $6.5M (Grant) on April 25, 2024.
  • neurocare raised $17M (Funding Round) on April 24, 2024.
  • Sydnexis raised $1000K (Series B) on April 24, 2024.

Who to call at Asgard Therapeutics, and when

A new round usually means Asgard Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Asgard Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Asgard Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Asgard Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Asgard Therapeutics

Location

Lund, Skåne County, Sweden

About

Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies for cancer immunotherapies. Formed as a spin-off from Lund University, the Company is pioneering a gene therapy approach based on its proprietary TrojanDC technology, designed to set in motion immune responses based on the biological properties of professional antigen presenting cells. Backed by Novo Holdings, Boehringer Ingelheim Venture Fund and Industrifonden, Asgard Therapeutics aims to build a pipeline of personalized cancer immunotherapies optimized to each unique patient.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Asgard Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsFabio R., Vice President, Head of Research hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Asgard Therapeutics's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Asgard Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.